Atlas Trials

Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in China

Clinical trial NCT07601516 · COMPLETED

Trial details

NCT number
NCT07601516
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Huntington's DiseaseChorea
Start date
2024-02-02
Primary completion
2025-10-24
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.